| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Moderna, Inc. | Director | Restricted Stock Units | 892 | $65.6K | $73.57 | Oct 2, 2024 | Direct |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | Director | Restricted Share Units | 14.5K | Jun 14, 2021 | Direct | ||
| Mallinckrodt plc | Director | Restricted Stock Units | 8.21K | Feb 19, 2024 | Direct | ||
| Moderna, Inc. | Director | Stock Option (Right to Buy) | 5.1K | Oct 2, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | Oct 2, 2024 | 4 | $0 | 4 | Oct 4, 2024 | Director |
| MRNA | Moderna, Inc. | Oct 2, 2024 | 0 | $0 | 3 | Oct 4, 2024 | Director |
| NONE | Mallinckrodt plc | Feb 19, 2024 | 1 | $0 | 4 | Feb 20, 2024 | Director |
| NONE | Mallinckrodt plc | Feb 2, 2024 | 0 | $0 | 3 | Feb 12, 2024 | Director |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Jun 14, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Director |